Melanoma Diagnostics Sells Genetic Marker Technology
socalTECH
DECEMBER 9, 2010
Altadena-based Melanoma Diagnostics , a developer of technology for the diagnosis and prognosis of malignant melanoma using genetic markers, is in a deal to sell its technology to Myriad Genetics , a publicly traded provider of molecular diagnostics products.
Let's personalize your content